DK1862544T3 - Polypeptider, som kan udløse en immunreaktion mod cancer - Google Patents

Polypeptider, som kan udløse en immunreaktion mod cancer

Info

Publication number
DK1862544T3
DK1862544T3 DK07105178.3T DK07105178T DK1862544T3 DK 1862544 T3 DK1862544 T3 DK 1862544T3 DK 07105178 T DK07105178 T DK 07105178T DK 1862544 T3 DK1862544 T3 DK 1862544T3
Authority
DK
Denmark
Prior art keywords
polypeptides
cancer
trigger
immune response
recognising
Prior art date
Application number
DK07105178.3T
Other languages
English (en)
Inventor
Gustav Gaudernack
Stein Saeboee-Larssen
Mona Moeller
Jon Amund Eriksen
Original Assignee
Gemvax As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9905720&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1862544(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gemvax As filed Critical Gemvax As
Application granted granted Critical
Publication of DK1862544T3 publication Critical patent/DK1862544T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
DK07105178.3T 2000-12-22 2001-12-18 Polypeptider, som kan udløse en immunreaktion mod cancer DK1862544T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0031430.2A GB0031430D0 (en) 2000-12-22 2000-12-22 Polypeptides
EP01272392A EP1352056B1 (en) 2000-12-22 2001-12-18 Polypeptides capable of eliciting an immune reaction against cancer

Publications (1)

Publication Number Publication Date
DK1862544T3 true DK1862544T3 (da) 2012-07-09

Family

ID=9905720

Family Applications (3)

Application Number Title Priority Date Filing Date
DK07105178.3T DK1862544T3 (da) 2000-12-22 2001-12-18 Polypeptider, som kan udløse en immunreaktion mod cancer
DK01272392T DK1352056T3 (da) 2000-12-22 2001-12-18 Polypeptider, der er i stand til at fremkalde en immunreaktion mod cancer
DK10183829.0T DK2361978T3 (da) 2000-12-22 2001-12-18 Polypeptider, som kan udløse en immunreaktion mod cancer

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK01272392T DK1352056T3 (da) 2000-12-22 2001-12-18 Polypeptider, der er i stand til at fremkalde en immunreaktion mod cancer
DK10183829.0T DK2361978T3 (da) 2000-12-22 2001-12-18 Polypeptider, som kan udløse en immunreaktion mod cancer

Country Status (14)

Country Link
US (4) US7078416B2 (da)
EP (3) EP1352056B1 (da)
JP (3) JP2004522433A (da)
AT (2) ATE550426T1 (da)
AU (3) AU2002216477B2 (da)
CA (2) CA2782510C (da)
CY (2) CY1106564T1 (da)
DE (1) DE60127715T2 (da)
DK (3) DK1862544T3 (da)
ES (2) ES2280311T3 (da)
GB (1) GB0031430D0 (da)
NO (2) NO332137B1 (da)
PT (2) PT1862544E (da)
WO (1) WO2002051994A2 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO315238B1 (no) * 1998-05-08 2003-08-04 Gemvax As Peptider som stammer fra leserammeforskyvingsmutasjoner i TBF<beta>II- eller BAX-genet, og farmasöytiske sammensetninger inneholdende disse,nukleinsyresekvenser som koder for slike peptider, plasmider og virusvektoreromfattende slikenukleinsy
AU2001241533A1 (en) * 2000-02-15 2001-08-27 The Regents Of The University Of California A universal vaccine and method for treating cancer employing telomerase reverse transcriptase
GB0031430D0 (en) * 2000-12-22 2001-02-07 Norsk Hydro As Polypeptides
ES2676503T3 (es) * 2002-12-16 2018-07-20 Globeimmune, Inc. Vacunas basadas en levadura como inmunoterapia
US8343502B2 (en) * 2002-12-16 2013-01-01 Globeimmune, Inc. Yeast-based vaccines as immunotherapy
US7439042B2 (en) * 2002-12-16 2008-10-21 Globeimmune, Inc. Yeast-based therapeutic for chronic hepatitis C infection
ES2527946T3 (es) * 2003-03-05 2015-02-02 Dendreon Corporation Composiciones y métodos que emplean polipéptidos de marco de lectura alternativa para el tratamiento de cáncer y enfermedades infecciosas
BRPI0516356A (pt) 2004-10-18 2008-09-02 Globeimmune Inc terapia à base de levedura para infecções crÈnicas da hepatite c
US9732131B2 (en) 2006-02-27 2017-08-15 Calviri, Inc. Identification and use of novopeptides for the treatment of cancer
WO2010033841A1 (en) 2008-09-19 2010-03-25 Globeimmune, Inc. Immunotherapy for chronic hepatitis c virus infection
GB0821616D0 (en) 2008-11-26 2008-12-31 Lytix Biopharma As Compounds
EP3576764A4 (en) 2017-02-03 2020-12-16 The Medical College of Wisconsin, Inc. KRAS PEPTIDE VACCINE COMPOSITIONS AND METHOD OF USE
WO2018223092A1 (en) 2017-06-02 2018-12-06 Arizona Board Of Regents On Behalf Of Arizona State University A method to create personalized cancer vaccines
US12025615B2 (en) 2017-09-15 2024-07-02 Arizona Board Of Regents On Behalf Of Arizona State University Methods of classifying response to immunotherapy for cancer
WO2021067550A1 (en) 2019-10-02 2021-04-08 Arizona Board Of Regents On Behalf Of Arizona State University Methods and compositions for identifying neoantigens for use in treating and preventing cancer

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803070A (en) 1986-04-15 1989-02-07 Ribi Immunochem Research Inc. Immunological emulsion adjuvants for polysaccharide vaccines
GB9103974D0 (en) 1991-02-26 1991-04-10 Norsk Hydro As Therapeutically useful peptides or peptide fragments
CN1270634A (zh) * 1997-07-01 2000-10-18 卡姆比亚生物系统有限责任公司 脊椎动物端粒酶基因和蛋白质及其用途
US6362784B1 (en) * 1998-03-31 2002-03-26 Matsuda Electric Industrial Co., Ltd. Antenna unit and digital television receiver
US6337200B1 (en) 1998-03-31 2002-01-08 Geron Corporation Human telomerase catalytic subunit variants
AU3456099A (en) 1998-03-31 1999-10-18 Geron Corporation Methods and compositions for eliciting an immune response to a telomerase antigen
NO315238B1 (no) 1998-05-08 2003-08-04 Gemvax As Peptider som stammer fra leserammeforskyvingsmutasjoner i TBF<beta>II- eller BAX-genet, og farmasöytiske sammensetninger inneholdende disse,nukleinsyresekvenser som koder for slike peptider, plasmider og virusvektoreromfattende slikenukleinsy
US7030211B1 (en) 1998-07-08 2006-04-18 Gemvax As Antigenic peptides derived from telomerase
JP2002541811A (ja) * 1999-04-09 2002-12-10 バイオミラ，インコーポレイテッド テロメラーゼ特異的癌ワクチン
JP2003518364A (ja) 1999-05-28 2003-06-10 ルードヴィッヒ インスティテュート フォー キャンサー リサーチ 乳癌、胃癌および前立腺癌関連抗原ならびにそれらの使用
GB0031430D0 (en) * 2000-12-22 2001-02-07 Norsk Hydro As Polypeptides

Also Published As

Publication number Publication date
ATE550426T1 (de) 2012-04-15
EP2361978B1 (en) 2015-10-14
AU2002216477B2 (en) 2007-05-24
EP1862544B1 (en) 2012-03-21
US20060194731A1 (en) 2006-08-31
US20120269858A1 (en) 2012-10-25
AU2002216477C1 (en) 2002-07-08
CA2432971C (en) 2012-09-04
CY1106564T1 (el) 2012-01-25
EP1352056A2 (en) 2003-10-15
DE60127715D1 (de) 2007-05-16
AU2007211889B2 (en) 2009-11-19
WO2002051994A3 (en) 2002-12-27
ES2280311T3 (es) 2007-09-16
PT1352056E (pt) 2007-05-31
EP1862544A1 (en) 2007-12-05
AU2010200620A1 (en) 2010-03-11
AU2007211889B8 (en) 2009-12-10
CY1112735T1 (el) 2016-02-10
EP2361978A1 (en) 2011-08-31
JP2012080883A (ja) 2012-04-26
DE60127715T2 (de) 2007-12-27
US7375117B2 (en) 2008-05-20
GB0031430D0 (en) 2001-02-07
EP1352056B1 (en) 2007-04-04
NO342257B1 (no) 2018-04-30
CA2782510A1 (en) 2002-07-04
WO2002051994A2 (en) 2002-07-04
NO20110429L (no) 2003-08-21
DK1352056T3 (da) 2007-05-29
CA2782510C (en) 2014-07-15
NO20032818L (no) 2003-08-21
JP2014138587A (ja) 2014-07-31
EP1862544B2 (en) 2016-03-09
US20080187551A1 (en) 2008-08-07
US8193326B2 (en) 2012-06-05
ES2382821T3 (es) 2012-06-13
DK2361978T3 (da) 2016-01-25
PT1862544E (pt) 2012-05-07
JP2004522433A (ja) 2004-07-29
AU2007211889A1 (en) 2007-09-13
NO332137B1 (no) 2012-07-02
CA2432971A1 (en) 2002-07-04
AU2007211889C1 (en) 2010-06-10
US20040072759A1 (en) 2004-04-15
AU2010200620B2 (en) 2012-11-01
WO2002051994A8 (en) 2003-03-06
US7078416B2 (en) 2006-07-18
ATE358716T1 (de) 2007-04-15
NO20032818D0 (no) 2003-06-19

Similar Documents

Publication Publication Date Title
NO20110429L (no) Polypeptider og nukleinsyre-DNA for anvendelse innen medisin
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
CY1117786T1 (el) Διαφορικα εκφραζομενα σε ογκους γονιδιακα προϊοντα και χρηση αυτων
CY1113421T1 (el) Πυρηνικα οξεα και πολυπεπτιδια υποδοχεα
DE69435075D1 (de) , die signalsequenzpeptide des endoplasmatischen reticulums und mindestens ein anderes peptid codieren, deren verwendung in impfstoffen und zur behandlung von krankheiten
AR020601A1 (es) Peptidos o proteinas de telomerasa para el tratamiento o profilaxis del cancer, composiciones farmaceuticas que incluyen dichos peptidos o proteinas, uso de dicha composicion para la fabricacion de medicamentos y el metodo para generar linfocitos t capaces de reconocer y destruir celulas tumorales c
ECSP093601A (es) Proteínas derivadas del virus del síndrome de mancha blanca y sus usos
ATE439372T1 (de) Nukleinsäuren und proteine von gruppen a und b- streptokokken
CY1117746T1 (el) Αντιγονα αιμοφιλου της γριπης και αντιστοιχα θραυσματα dna
WO2002080851A3 (en) Chimeric vaccines
AU2003242305A8 (en) Hla-a24-restricted cancer antigen peptide
AU5810201A (en) Immunogenic polypeptides encoded by mage minigenes and uses thereof
ATE392477T1 (de) Agarase und gen dafür
HUT71847A (en) Dna molecules encoding aminopeptidase enzymes, vectors and transgenic cells containing dna molecules, immunogenic polypeptides encoding by dna molecules, vaccines against helminth infections containing these peptides and process for the preparation ...
WO2020022898A3 (en) Off-the-shelf cancer vaccines
DK1536006T3 (da) Cancerantigener og anvendelse deraf
GB0118532D0 (en) Materials and methods relating to improved vaccination strategies
WO2002036627A3 (en) Interferons, uses and compositions related thereto
WO2003093298A3 (en) Immunogenic peptides
WO2003093431A3 (en) Ablated slam-dependent entry
WO2002088380A3 (en) Immunogenic tumor antigens: nucleic acids and polypeptides encoding the same and methods of use thereof
WO2002066652A3 (en) Ehrlichia ruminantium polypeptides, antigens, polynucleotides, and methods of use
DK0980379T3 (da) Chimære oligonucleotider og deres anvendelse
CY1116106T1 (el) Μεθοδος προληψης ή θεραπεια μολυνσης m. tuberculosis
TH55539B (th) เพปไทด์ที่เป็นแอนติเจน